Back
EyePoint Pharmaceuticals Vs. BNP Paribas Industry Stock Comparison
Sell
40
EYPT
EyePoint Pharmaceuticals
Last Price:
$6.64
Seasonality Move:
-1.71%
Buy
55
BNPQF
BNP Paribas
Last Price:
$86.65
Seasonality Move:
1.34%
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
-
The current EyePoint Pharmaceuticals [EYPT] share price is $6.78. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
BNP Paribas (BNPQF)
is a Buy
Is BNP Paribas a Buy, Sell or Hold?
-
The current BNP Paribas [BNPQF] share price is $84.54. The Score for BNPQF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
BNPQF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $6.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BNPQF Stock Price Chart
What is BNP Paribas's stock price today?
-
The BNP Paribas share price today is $84.54Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BNPQF is experiencing selling pressure, which indicates risk of future bearish movement.
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 62.18 | Buy |
Chaikin Money Flow: | 417062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.91 - 6.35) | Buy |
Bollinger Bands (100): | (5.76 - 8.02) | Sell |
BNPQF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.95 | Buy |
Relative Strength Index (14 RSI): | 57.96 | Buy |
Chaikin Money Flow: | -2791 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (76.17 - 85.01) | Buy |
Bollinger Bands (100): | (62.4 - 80.84) | Buy |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.25 | Buy |
20-day SMA: | 5.52 | Buy |
50-day SMA: | 6.04 | Buy |
200-day SMA: | 8.11 | Sell |
8-day EMA: | 6.28 | Buy |
20-day EMA: | 5.94 | Buy |
50-day EMA: | 6.18 | Buy |
200-day EMA: | 8.38 | Sell |
BNPQF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 81.79 | Buy |
20-day SMA: | 79.35 | Buy |
50-day SMA: | 79.75 | Buy |
200-day SMA: | 69.63 | Buy |
8-day EMA: | 82.08 | Buy |
20-day EMA: | 80.68 | Buy |
50-day EMA: | 78.38 | Buy |
200-day EMA: | 71.44 | Buy |
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
BNP Paribas Earnings Growth & BNPQF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
EyePoint Pharmaceuticals Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BNP Paribas Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |